Tempest Therapeutics holds special stockholder meeting
TPST•Tempest Therapeutics adjourned its reconvened special stockholder meeting after a charter amendment failed to secure enough votes. The meeting will reconvene December 11, 2026, for additional voting on the unchanged proposal.
1. Meeting adjourned
Tempest Therapeutics adjourned its reconvened special stockholder meeting held November 12, 2026. A proposal to replace specified supermajority voting requirements and permit stockholder action by written consent did not receive sufficient votes for approval; the meeting will reconvene December 11 for additional voting on the unchanged proposal.




